Rockefeller Capital Management L.P. Twist Bioscience Corp Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$11.49 - $20.46 $9,697 - $17,268	-844 Reduced 7.68%	10,144 $207,000
Q1 2023 May 17, 2023	BUY	$14.6 - $30.9 $89,045 - $188,459	6,099 Added 124.75%	10,988 $165,000
Q4 2022 Mar 06, 2023	SELL	$21.92 - $39.37 $487,829 - $876,179	-22,255 Reduced 81.99%	4,889 $116,000
Q3 2022 Nov 02, 2022	BUY	$33.44 - $56.56 $56,312 - $95,247	1,684 Added 6.61%	27,144 $956,000
Q2 2022 Aug 12, 2022	BUY	$26.2 - $54.0 $53,945 - $111,186	2,059 Added 8.8%	25,460 $890,000
Q1 2022 May 13, 2022	BUY	$38.58 - $83.27 $76,388 - $164,874	1,980 Added 9.24%	23,401 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$75.47 - $135.88 $277,956 - $500,446	3,683 Added 20.76%	21,421 $1.66 Million
Q3 2021 Nov 12, 2021	BUY	$95.64 - $131.48 $1.08 Million - $1.49 Million	11,330 Added 176.81%	17,738 $1.9 Million
Q2 2021 Aug 10, 2021	BUY	$88.13 - $142.06 $537,593 - $866,566	6,100 Added 1980.52%	6,408 $853,000
Q1 2021 May 11, 2021	SELL	$105.48 - $207.97 $59,279 - $116,879	-562 Reduced 64.6%	308 $38,000
Q4 2020 Feb 12, 2021	BUY	$76.64 - $167.89 $66,676 - $146,064	870 New	870 $122,000

256

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.35B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.